Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results Mar 4, 2026 04:01PM
Keros Therapeutics Reports Third Quarter 2025 Financial Results Nov 5, 2025 04:01PM
ADAR1 Issues Statement on Keros Therapeutics (KROS) 2025 Director Election Results and Insufficient Capital Return Proposal Jun 9, 2025 03:14PM
ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal Jun 9, 2025 03:12PM
Keros Therapeutics (KROS) Announces TROPOS Topline Data and Corporate Restructuring May 29, 2025 06:55AM


May 29, 2025 06:55AM Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring
May 8, 2025 02:10PM ADAR1 Capital Management Issues Open Letter to Keros Therapeutics (KROS) Stockholders
May 8, 2025 02:10PM ADAR1 Capital Management Issues Open Letter to Keros Therapeutics Stockholders